Blueberry Fermentation Tech: BBS Bioscience Development

[[투데이타임즈 = 민경만 기자] Bio healthcare research company ‘㈜Human Bioscience’A new material developed by a research team by fermenting blueberries. BBS(Bioconverted Blueberry SCFAs)Relief of intestinal inflammation and intestinal–brain axis(Gut-Brain Axis)It was revealed that it showed the possibility of improving cognitive health through.

Recently published in an international academic journal ㈜ Human Bioscience(CEO Lim Byeong-woo)It was registered as the result of a joint research conducted by Professor Seong-kwon Moon’s team in the Department of Food and Nutrition, Department of Food Science and Technology, Chung-Ang University. Journal of functional Food (Paper title: Propionic acid-rich fermented blueberry supernatant improves DSS-induced colitis symptoms by regulating inflammatory pathways, 2025year 10month 133side) According to the paper, Propionic acid in animal models of inflammatory bowel disease(propionic acid)containing BBSIngredients NF-kBand COX-2 Results were reported to promote recovery of intestinal inflammation by regulating the inflammatory pathway.. especially, The results of this study confirmed that it contributed to maintaining immune balance and protecting the intestinal barrier by suppressing inflammatory mediating signals from macrophages and intestinal epithelial cells..

BBSAnthocyanins, which are abundant in blueberries, and short-chain fatty acids produced during fermentation.(SCFA) This is a new complex fermentation material containing. ㈜ The Human Bioscience research team found that this substance does not just reduce intestinal inflammation;, It was explained that it showed the possibility of improving memory and cognitive function through direct interaction between intestinal microbial metabolites and the nervous system..

also, A research team official “BBSis a new fermentation material based on edible natural products that can ensure both safety and efficacy., page–Research utilizing the brain axis mechanism has great scalability.”as “In the future, we plan to continue research and development with next-generation convergence bio innovative materials with the goal of developing not only health functional food ingredients but also treatments for mild cognitive impairment and inflammatory bowel disease.”said.

This development achievement is evaluated as a new and creative approach that can complement the limitations and side effects of existing chemical compound-centered treatments.. especially, inflammatory bowel disease(IBD)At the present time, the number of patients with mild cognitive impairment continues to increase steadily. BBSIt is expected that commercialization will become an important foundation for securing competitiveness in the domestic and international bio healthcare market../min